The present invention aims to provide compounds which have an inhibitory effect on the binding between S1P and its receptor Edg-1(S1P
1
) and which are useful for pharmaceutical purposes.
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof:
[wherein Ar represents a monocyclic heterocyclic ring containing one or two nitrogen atoms, A represents an oxygen atom or the like, Y
1
, Y
2
and Y
3
each represent a carbon atom or a nitrogen atom, R
1
represents a hydrogen atom, a C
1
-C
6
alkyl group or the like, R
2
represents a C
1
-C
6
alkyl group, a C
3
-C
8
cycloalkyl group or the like, R
3
represents a C
1
-C
18
alkyl group or the like, R
4
represents a hydrogen atom or a C
1
-C
6
alkyl group, and R
5
represents a C
1
-C
10
alkyl group or the like].
本发明旨在提供一种对S1P与其受体Edg-1(S1P1)之间结合具有抑制作用且可用于药物目的的化合物。化合物由公式(I)或其药学上可接受的盐表示:[其中Ar表示含有一个或两个
氮原子的单环杂环,A表示
氧原子或类似物,Y1、Y2和Y3分别表示
碳原子或
氮原子,R1表示
氢原子、C1-C6烷基或类似物,R2表示C1-C6烷基、C3-C8
环烷基或类似物,R3表示C1-C18烷基或类似物,R4表示
氢原子或C1-C6烷基,R5表示C1-C10烷基或类似物。]